Header Logo

Connection

JOHN VIERLING to Tacrolimus

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Tacrolimus.
JOHN VIERLING
Connection Strength
0.162
Tacrolimus
  1. Evolving new therapies of autoimmune hepatitis. Clin Liver Dis. 2002 Aug; 6(3):825-50, ix.
    View in: PubMed
    Score: 0.046
  2. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
    View in: PubMed
    Score: 0.043
  3. Expert clinical management of autoimmune hepatitis in the real world. Aliment Pharmacol Ther. 2017 03; 45(5):723-732.
    View in: PubMed
    Score: 0.031
  4. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc. 1996 Apr; 28(2):1011-3.
    View in: PubMed
    Score: 0.029
  5. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. Aliment Pharmacol Ther. 2004 May 01; 19(9):1033-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.